Komori
Treasury Stock5187CREATE MEDIC CO.,LTD.Electrical Equipment and Precision Instruments

Notice Regarding the Acquisition of Treasury Shares and the Purchase of Treasury Shares Through an Off-Auction Own-Share Purchase Transaction (ToSTNeT-3)

The Board of Directors resolved to acquire up to 430,000 ordinary shares for a total purchase price of up to ¥520 million. The Company plans to first purchase 230,000 shares through ToSTNeT-3 and then purchase the remaining shares through market purchases on the Tokyo Stock Exchange until the limit is reached.

Worth reading
85Important
Scored from 3 of 5 sections
Direction
Improvement
Direction inferred from the company’s description.
Scale
430000
Shares
Wording
Conditional
How definitive the wording is.

Resolution on acquisition limit

Resolved 27 March 2026Off-auction purchase transaction for treasury shares (ToSTNeT-3) and market purchases on the Tokyo Stock Exchange
Total acquisition price¥520,000,000 (maximum)
Maximum number of shares to be acquired430,000 shares (maximum)The Company's common shares
Acquisition period

30 March 2026 to 31 October 2026

Reason for acquisition

To further enhance shareholder returns

Reference (number of shares stated in the document)
Current number of treasury shares1,279,220 shares (as of 31 December 2025)
Total number of issued shares8,385,107 shares (excluding treasury shares, as of 31 December 2025)
Resolution on acquisition limit
ItemDetails
Class of shares to be acquiredThe Company's common shares
Maximum number of shares to be acquired430,000 shares (maximum)
Total acquisition price¥520,000,000 (maximum)
Acquisition period30 March 2026 to 31 October 2026
Method of acquisitionOff-auction purchase transaction for treasury shares (ToSTNeT-3) and market purchases on the Tokyo Stock Exchange
Reason for acquisitionTo further enhance shareholder returns
Resolution date27 March 2026
Current number of treasury shares1,279,220 shares (as of 31 December 2025)
Total number of issued shares8,385,107 shares (excluding treasury shares, as of 31 December 2025)
Items this document does not state (7)
Percentage of total issued sharesNumber of shares to be retiredPercentage of total issued shares before retirementScheduled retirement dateTotal number of issued shares after retirementChange in acquisition periodChange in acquisition limit

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The Company considers the pursuit of management that is conscious of the cost of capital and share price, the enhancement of corporate value over the medium to long term, and the return of profits to shareholders to be important priorities, and will further enhance shareholder returns.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Acquisition of Treasury Shares and the Purchase of Treasury Shares Through an Off-Auction Own-Share Purchase Transaction (ToSTNeT-3) | CREATE MEDIC CO.,LTD. (5187) timely disclosure | Komori